Equibles does not estimate personal net worth.
Get an email with a short summary when ChronoScale Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get CHRN alertsJerome Wong is recorded as CFO at ChronoScale Holdings Corp (CHRN). The newest filing on record that lists Jerome Wong as CFO at ChronoScale Holdings Corp (CHRN) is dated September 25, 2026. ChronoScale Holdings Corp reported in an 8-K filed October 31, 2022 that Jerome Wong was appointed Chief Financial Officer, Corporate Secretary and Principal Financial Officer, effective October 26, 2022. The proxy statement of ChronoScale Holdings Corp reports total compensation of $491,625 for Jerome Wong in fiscal 2025, including a base salary of $325,000. Disclosed compensation is on record for 4 fiscal years. Jerome Wong has spoken on 13 earnings calls and 1 other investor event across 1 company, most recently for ChronoScale Holdings Corp on November 6, 2026. ChronoScale Holdings Corp is classified in the Information Technology Services industry within the Technology sector. Other leadership on record at ChronoScale Holdings Corp includes Scott Davis (CEO and COO), Ying Cenly Chen (CEO and Board Member), Wes Cummins (Chairman) and 7 others.
“On October 26, 2022, Ekso Bionics Holdings, Inc.'s (the "Company") board of directors (the "Board") approved the appointment of Jerome Wong as Chief Financial Officer, Corporate Secretary and Principal Financial Officer, effective immediately.”
“The inspector of election has informed me that, on a preliminary basis, with respect to proposal number one, all seven director nominees were elected as directors of the company until the next annual meeting of our stockholders.”
“On behalf of the management team and everyone at Ekso Bionics, I would like to thank you for your interest in our company. And for those of you who are shareholders, we appreciate your support.”
“On behalf of the management team and everyone at Ekso Bionics, I would like to thank you for your interest in our company. And for those who are shareholders, we appreciate your support.”
“Good afternoon, everyone, and welcome to our Fourth Quarter and Full Year 2024 Conference Call. On behalf of the management team and everyone at Ekso Bionics Holdings, Inc., I would like to thank you for your interest in our company.”
“We generated quarterly sales of $4.1 million in the third quarter of 2024 compared to $4.6 million for the third quarter of 2023. Gross profit for the third quarter of 2024 was $2.2 million, representing a gross margin of approximately 53.5% compared to gross margin of 53.3% in the third quarter of 2023.”
Start not stated–present
Last confirmed September 25, 2026
Information Technology Services · Technology
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | ChronoScale Holdings Corp (CHRN) | Chief Financial Officer | $325,000 | $491,625 |
| 2024 | ChronoScale Holdings Corp (CHRN) | Chief Financial Officer and Corporate Secretary | $325,000 | $394,850 |
| 2023 | ChronoScale Holdings Corp (CHRN) | Chief Financial Officer and Corporate Secretary | $325,000 | $726,084 |
| 2022 | ChronoScale Holdings Corp (CHRN) | Chief Financial Officer | $251,644 | $506,811 |
